Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment
Thompson, R.F.; Davenport, J.
Missouri Medicine 81(10): 669-673
1984
ISSN/ISBN: 0026-6620 PMID: 6092887 Document Number: 229388
Document emailed within 1 workday
Related Documents
Rysková, O.; Vejbora, O.; Chromová, L.; Pekárek, J.; Chmelar, V.; Zaydlar, K. 1981: Cellular immunity in multiple sclerosis Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 24(1): 85-91Demina, T.L.; Boĭko, A.N.; Balashov, K.E.; Pinegin, B.V. 1989: Characteristics of cellular immunity in multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 89(2): 35-41
Dau, P.C.; Johnson, K.P.; Spitler, L.E. 1976: The effect of levamisole on cellular immunity in multiple sclerosis Clinical and Experimental Immunology 26(2): 302-309
Dziuba, A.N.; Frolov, V.M.; Gaĭdash, I.S. 1992: Indicators of cellular immunity in patients with multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(2): 12-14
Atanadze, S.N.; Kodkind, G.K.; Smirnov YuK; Khomak, V.I.; Veĭn, A.M. 1980: Measles cellular immunity in patients with multiple sclerosis Voprosy Virusologii 2: 166-169
Riggs, J.E.; Schochet, S.S.; Kopitnik, T.A.; Gutmann, L. 1986: Target fibers in multiple sclerosis: implications for pathogenesis Neurology 36(2): 297-298
Yamamura, T. 1994: New strategies for treatment of multiple sclerosis based on the autoimmune pathogenesis Nihon Rinsho. Japanese Journal of Clinical Medicine 52(11): 3026-3031
Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Shishiba, Y. 1978: Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity Nihon Rinsho. Japanese Journal of Clinical Medicine 36(5): 960-966
Lehmann, P.V.; Rottlaender, A.; Kuerten, S. 2015: The autoimmune pathogenesis of multiple sclerosis Die Pharmazie 70(1): 5-11
Nouza, K.; Krejcová, H. 1997: Pathogenesis and therapy of multiple sclerosis Bratislavske Lekarske Listy 98(4): 199-203
Szczuciński, A.; Losy, J. 2006: Infectious agents in the pathogenesis of multiple sclerosis Przeglad Epidemiologiczny 60(Suppl 1): 160-165
Bayliss, O.B.; Adams, C.W. 1971: Cellular lipid inclusions in the white matter in multiple sclerosis Nature 233(5317): 264-265
Correale, J. 2000: Immunological mechanisms involved in the pathogenesis of multiple sclerosis Revista de Neurologia 31(5): 471-476
Sheremata, W.; Wood, D.D.; Moscarello, M.A. 1976: Antimyelin basic protein antibodies and cellular hypersensitivity in multiple sclerosis Transactions of the American Neurological Association 101: 291-294
Bernard, C.C. 1989: Influence of genetic factors on cell-mediated and humoral immunity in multiple sclerosis Israel Journal of Medical Sciences 25(12): 682-685
Neu, I. 1977: Pathogenesis of multiple sclerosis. Work-hypotheses and experimental data Fortschritte der Medizin 95(9): 535-538
Mititelu, G.; Stirbu, C.; Bourceanu, I.; Mititelu, T. 1987: Is the immune response to canine morbillivirus in multiple sclerosis a reflex of the measles pre-existing immunity? Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 91(4): 741-742
Zavalishin, I.A.; Dziuba, A.N.; Khokhlov, A.P.; Savchenko, I.N. 1987: Significance of N-methyl amino acids in the diagnosis and pathogenesis of multiple sclerosis Vrachebnoe Delo 12: 68-70